AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2022
Mar 2, 2022
35221_dirs_2022-03-01_5bfa2048-90e7-4973-baa9-b04bb1778e8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2021-06-15
Reporting Person: Baxter Timothy E (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-15 | Employee stock option (right to buy) | $5.79 | A | 75000 | Acquired | 2031-06-15 | Common stock (75000) | Direct |
Footnotes
F1: The option vests in 12 quarterly installments, commencing on June 30, 2021.
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23